Rare
lephants
Screener
Toggle theme
AXIM Biotechnologies, Inc.
AXIM
·
Healthcare, Drug Manufacturers - General, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Profit History
Profit Flow
Profit Margins
Returns on Capital
Profitability
›
Profit History
Annual
Quarterly
Compare
←
5Y
10Y
MAX
→
Profit History
Chart
Table
Revenue
Operating Income
Net Income
Fiscal Year
Revenue
Operating Income
Net Income
FY2023
$39.5K
$-2.8M
$-8.1M
Download CSV
